2Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20 536 people with peripheral arterial disease and other high-risk conditions. J Vase Surg,2007,45 (4) : 645-654.
3Shepherd J, Blauw GJ, Murphy MB, et al, Pravastatin in elderly individuals at risk of vascular disease (PROSPER) : a randomised controlled trial. Lancet,2002,360(9346) : 1623-1630.
4Poynter JN,Gruber SB,Higgins PD,et al. Statins and the risk of colorectal cancer. N Engl J Med ,2005,352(21):2184-2192.
5Koornstra JJ,Kleibeuker JH. Statins for the prevention of eoloreetal carcinoma: not yet recommended. Ned Tijdschr Geneeskd, 2005,149 (43) :2388-2391.
6Dale KM,Coleman CI,Henyan NN,et al. Statins and cancer risk:a meta-analysis. JAMA, 2006,295 (1): 74-80.
7.Executive summary of the third report of the national cholesterol educa-tion program and treatment of high blood cholesterol in adults(Adulttreatment panelⅢ)[].J AMMed Aso.2001
8Ridker PM,Rifai N,Rose I,et al.Comparison of C-reactive proteinand lowdensity lipoprotein cholesterol levels in the prediction of first car-diovascular events[].The New England Journal of Medicine.2002
9Van W issen S,,Trip MD,Smilble TJ et al.Differential hs-CRP redu-cation in patients with familial hypercholesterolem in treated with aggres-sive or conventional statin therapy[].Atherosclerosis.2002
10RIDKER PM.Clinical application of C-reactive protein for cardio-vascular disease detection and prevention[].Circulation.2003
